Article Information
History
- July 16, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- K Basile1,*,
- K McPhie1,4,
- I Carter1,
- S Alderson1,
- H Rahman1,
- L Donovan1,
- S Kumar1,
- T Tran1,
- D Ko1,
- T Sivaruban1,
- C Ngo1,
- C Toi1,
- MV O’Sullivan1,2,3,
- V Sintchenko1,2,3,
- S C-A Chen1,2,3,
- S Maddocks1,
- DE Dwyer1,2,3 and
- J Kok1,2
- 1Centre for Infectious Diseases and Microbiology Laboratory Services, NSW Health Pathology - Institute of Clinical Pathology and Medical Research, Westmead NSW 2145, Australia
- 2Centre for Infectious Diseases and Microbiology – Public Health, Westmead Hospital, Westmead NSW 2145, Australia
- 3Marie Bashir Institute for Infectious Diseases and Biosecurity, Sydney Medical School, The University of Sydney, NSW 2006, Australia
- 4Westmead Institute for Medical Research, Westmead, NSW 2145, Australia
- ↵*Corresponding author: Dr Kerri Basile
, kerri.basile{at}health.nsw.gov.au, Centre for Infectious Diseases and Microbiology Laboratory Services, NSW Health Pathology-Institute of Clinical Pathology and Medical Research, Westmead Hospital Westmead NSW 2145 AUSTRALIA, +612 88906255
Posted July 16, 2020.
Cell-based culture of SARS-CoV-2 informs infectivity and safe de-isolation assessments during COVID-19
